Nearly all breast cancer tissues expressed estrogen receptor (ER, 90.5% of samples) and progesterone receptor (PR, 70% of samples), meaning that luminal molecular subtype (91.6%) prevailed in evaluated samples. Here, PGR is linked to breast carcinoma.